The U.S. telemedicine market was valued at USD 35.9 billion in 2025, is expected to reach USD 41.64 billion in 2026, and is projected to grow at a 16% CAGR (2025–2035) to reach USD 155.93 billion by 2035. The market covers technology-enabled healthcare delivery across real-time consultations, remote patient monitoring, asynchronous care, and integrated digital platforms serving providers, payers, and patients.
Growth is being shaped by the operational integration of virtual care into clinical workflows rather than by a temporary utilization surge. Provider organizations are using telemedicine to extend specialty capacity, manage chronic conditions between in-person encounters, and support distributed care models, while payers are incorporating virtual access into benefit design, network strategy, and utilization management.
GMI Analyst View
Based on our ongoing engagement with market participants and primary research across the U.S. healthcare ecosystem, U.S. telemedicine market revenue reached USD 30.78 billion in 2024. We view this as evidence that the market had already progressed beyond pandemic-era experimentation before the 2025 base year, shifting competitive emphasis toward measurable clinical performance, payer integration, and durable specialty-care workflows.
U.S. Telemedicine Market Trends, Growth Drivers & GMI Forecast Outlook
The market outlook rests on a widening mismatch between clinical demand and conventional care capacity. Behavioral health access constraints, reimbursement-supported platform adoption, and more efficient digital workflows are expanding demand, while cybersecurity obligations, infrastructure gaps, and reimbursement ambiguity continue to determine where and how quickly deployment can scale.
Key Drivers
Driver
Evidence signal
Market-demand implication
GMI forecast condition
Behavioral health workforce shortage
More than 122 million people lived in a Mental Health Professional Shortage Area as of December 2024 [1]Bureau of Health Workforce, Health Resources and Services Administration. "Mental Health Providers." countyhealthrankings.org
Unfilled in-person capacity is rerouted to tele-psychiatry and behavioral health platforms
Persistent shortage sustains above-market growth in psychiatry through 2030
23% of eligible Medicare Part B fee-for-service beneficiaries used telehealth in 2025 [2]Centers for Medicare & Medicaid Services. "Medicare Telehealth Trends Snapshot." data.cms.gov
Stable reimbursement establishes a platform-contracting baseline
CMS reimbursement anchors platform investment cycles through the forecast period
AI-enabled platform integration
Clinical AI for documentation automation, predictive RPM triage, and asynchronous diagnostics is embedded into leading platforms
Lower cost per encounter improves unit economics, enabling service-line expansion
Scale efficiencies drive accelerating software attach rates and hardware deployment through 2035
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Behavioral health is a particularly durable demand channel because virtual delivery can address both provider scarcity and the practical barriers that delay treatment, including travel, scheduling, and fragmented local networks. Tele-psychiatry vendors are therefore competing not simply for visit volume, but for placement within payer networks, employer benefits, and provider referral pathways where clinical capacity is a constrained asset.
Medicare participation provides an important commercial floor for health systems and platform vendors making multi-year investments in virtual care infrastructure. Once reimbursement is sufficiently dependable, procurement decisions can shift from isolated video-visit programs toward integrated workflows that connect scheduling, documentation, patient engagement, and monitoring across specialty service lines.
AI integration is also changing the economics of platform deployment. Documentation assistance, triage tools, and asynchronous clinical workflows can reduce administrative friction around each encounter, improving the viability of virtual models in lower-acuity settings where direct clinical time and support costs would otherwise limit adoption.
Key Restraints
Restraint
Evidence signal
Market-demand implication
GMI forecast condition
Cybersecurity risk imposing compliance cost
Healthcare recorded an average data breach cost of USD 7.42 million in 2025 — the highest of any industry for the 14th consecutive year [3]HIPAA Journal. "Average Cost of a Healthcare Data Breach Falls to $7.42 Million." hipaajournal.com
Elevated breach cost increases security capital expenditure and slows certification cycles
Compliance burden compresses margins for mid-tier telehealth vendors through 2030
Rural broadband infrastructure gap
22.3% of rural Americans lack access to fixed terrestrial broadband at minimum speed thresholds per FCC data cited by USDA [4]U.S. Department of Agriculture. "Broadband." usda.gov
Real-time video consultations are infeasible for a material share of rural patients
Deployment timelines extend to the mid-2030s, constraining rural addressable market expansion
Reimbursement uncertainty for asynchronous modalities
Payer coverage policies for asynchronous care remain inconsistent across commercial, Medicare Advantage, and Medicaid managed care contracts
Vendor uncertainty dampens R&D investment in store-and-forward platforms
Resolution of reimbursement policy by 2027–2028 is a condition for above-trend growth in specialty segments
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cybersecurity has become a commercial qualification issue as much as a technical one. Large providers and health plans increasingly expect vendors to meet demanding security, audit, interoperability, and incident-response requirements before virtual-care programs can move beyond pilots. These obligations favor vendors with established compliance infrastructure and can lengthen sales cycles for smaller specialists.
Broadband limitations create a different constraint: they reduce the practical reach of synchronous care precisely where specialty access needs may be most acute. Audio-first care models can partly mitigate this barrier, but remote monitoring, high-quality video, and data-intensive workflows require connectivity conditions that remain uneven across rural communities.
GMI Analyst View
We expect market development to favor platforms that can combine clinical operations, security controls, analytics, and reimbursement-aware workflows rather than offering video access as a stand-alone service. The principal restraints are likely to shape the timing and channel mix of expansion, not reverse the underlying shift toward digitally coordinated care.
U.S. Telemedicine Market Segment Analysis
By Component
Hardware
The U.S. telemedicine market hardware segment generated USD 7.18 billion in 2025 and is projected to grow at a 14.5% CAGR (2025–2035). Connected diagnostic peripherals, home-monitoring devices, and clinical communication equipment remain essential to care models that require physiological data or specialist oversight beyond a conventional virtual consultation.
Hardware demand is increasingly tied to the design of chronic-care and post-acute programs. Vendors that can connect devices reliably into clinical workflows, rather than merely supply equipment, are better positioned to participate in recurring remote patient management contracts.
Software — Cloud-based
Cloud-based software accounted for 27% of the market in 2025 and is projected to grow at an 18.2% CAGR (2025–2035). Its scale reflects demand for interoperable, multi-site platforms that can support payer programs, provider networks, and distributed clinical teams without the operational burden of locally managed infrastructure.
The segment benefits from the need to coordinate scheduling, documentation, patient communication, and data exchange across care settings. Cloud architectures are particularly relevant where organizations want to standardize virtual-care delivery across multiple specialties and geographies.
Software — On-premises
On-premises software generated USD 2.87 billion in 2025 and is projected to grow at a 9.0% CAGR (2025–2035). The segment remains relevant in organizations with restrictive governance requirements, established clinical technology estates, or deployment preferences that limit migration to externally hosted environments.
Its slower trajectory reflects the trade-off between data-control priorities and the flexibility required for fast feature deployment. Renewal revenue and institutional integration can preserve demand, but the strategic center of gravity is moving toward platforms that can scale across networks more readily.
Services — Tele-consultation
Tele-consultation represented 22% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). It remains the foundational service modality for behavioral health, urgent care, follow-up care, and specialty access, where clinician availability and patient convenience directly influence utilization.
Competitive performance depends on provider-network depth, wait-time management, clinical quality, and reimbursement alignment. As virtual visits become a routine care option, service differentiation is moving from basic access toward specialty appropriateness and continuity with in-person care.
Services — Tele-monitoring
Tele-monitoring generated USD 4.67 billion in 2025 and is projected to grow at an 18.0% CAGR (2025–2035). Demand is being supported by chronic-condition programs that require ongoing visibility into patient status between office visits, particularly where avoidable escalation or hospitalization carries significant clinical and financial consequences.
The segment's appeal lies in its ability to connect device data, clinical review, and patient outreach in a single operating model. Better alert prioritization and workflow integration can make monitoring programs more scalable for providers and more actionable for payers.
Services — Tele-education & Training
Tele-education and training accounted for 5% of the market in 2025 and is projected to grow at a 14.0% CAGR (2025–2035). The segment supports clinical onboarding, workforce development, patient education, and adoption of new digital-care workflows across provider organizations.
Its expansion is linked to implementation intensity. As telemedicine platforms become embedded in more care settings, health systems and specialty practices need repeatable methods to train clinicians, support staff, and patients without disrupting care delivery.
By Specialty Area
Psychiatry
Psychiatry generated USD 7.90 billion in 2025 and is projected to grow at an 18.5% CAGR (2025–2035). The specialty benefits from a structural mismatch between mental health demand and available licensed clinical capacity, making virtual delivery a practical route to expand access across payer, employer, and provider channels.
The segment's commercial strength is reinforced by the suitability of many psychiatric consultations for recurring remote engagement. Sustained growth will depend on provider recruitment, prescribing workflows, clinical governance, and the ability to integrate virtual behavioral health with broader care-management programs.
Cardiology
Cardiology generated USD 6.46 billion in 2025 and is projected to grow at a 16.8% CAGR (2025–2035). Remote oversight is increasingly relevant for patients requiring longitudinal monitoring, follow-up after procedures, and specialist access outside major cardiovascular centers.
The segment benefits from the interaction between specialist consultation and connected data streams. Tele-cardiology models become more valuable when they help clinical teams identify deterioration earlier, coordinate referrals, and manage high-risk patients across hospital and home settings.
Endocrinology
Endocrinology represented 10% of the market in 2025 and is projected to grow at a 17.2% CAGR (2025–2035). Diabetes management, connected monitoring, and preventive coaching make the specialty well suited to longitudinal virtual-care relationships.
The opportunity extends beyond individual consultations. Virtual endocrinology programs can link clinicians, educators, monitoring tools, and payer-sponsored population-health initiatives, giving the segment a role in both specialty access and chronic-disease management.
Oncology
Oncology accounted for 8% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). Virtual services are increasingly used for navigation, symptom reporting, counseling, and follow-up between in-person treatment events.
Clinical value is strongest where telemedicine complements rather than replaces intensive care delivery. Programs that improve communication between treatment cycles and identify problems early can reduce avoidable patient burden while preserving specialist oversight.
Pulmonology
Pulmonology generated USD 2.87 billion in 2025 and is projected to grow at a 15.0% CAGR (2025–2035). Demand is supported by virtual follow-up and remote monitoring for patients with chronic respiratory conditions who need ongoing assessment but may have limited local access to specialists.
The segment's trajectory depends on reliable patient engagement and usable clinical data. Care models that translate home-based measures into timely clinical action are likely to be more durable than programs centered solely on remote device deployment.
Gastroenterology
Gastroenterology generated USD 2.51 billion in 2025 and is projected to grow at a 15.5% CAGR (2025–2035). Virtual consultations can improve referral triage, chronic-condition follow-up, and preparation for in-person diagnostic or procedural care.
The specialty's telemedicine model is particularly effective when it helps clinicians determine the appropriate next step before patients enter capacity-constrained procedural pathways. This can improve scheduling efficiency while preserving in-person resources for care that requires them.
Gynecology
Gynecology represented 6% of the market in 2025 and is projected to grow at a 14.8% CAGR (2025–2035). Virtual care aligns with patient needs in areas such as counseling, follow-up, reproductive health, and selected prenatal or postpartum interactions.
Privacy, convenience, and continuity make virtual delivery commercially relevant, but sustained adoption depends on how well platforms integrate with established women's-health practices and referral pathways for services requiring in-person examination or intervention.
Rheumatology
Rheumatology accounted for 5% of the market in 2025 and is projected to grow at a 14.2% CAGR (2025–2035). Chronic disease management and the need for periodic specialist follow-up create a practical basis for hybrid care models that combine virtual reviews with targeted in-person assessment.
Tele-rheumatology can be especially meaningful in areas with limited specialist density. Its value proposition centers on maintaining clinical continuity and reducing travel burden without compromising escalation pathways when symptoms require direct examination.
Other Specialties
Other specialties accounted for 16% of the market in 2025 and are projected to grow at a 14.0% CAGR (2025–2035). This grouping includes clinical disciplines where asynchronous review, specialist consultation, and institutional coverage models can extend access beyond traditional appointment-based care.
The diversity of these use cases means adoption will not be uniform. Specialties with clearly defined digital workflows, strong referral economics, or urgent access requirements are more likely to scale than those in which the virtual encounter adds limited clinical value.
By End Use
Healthcare Providers
Healthcare providers generated USD 19.75 billion in 2025 and are projected to grow at a 15.5% CAGR (2025–2035). Within this end-use group, Hospitals & Clinics generated USD 12.57 billion in 2025, while Long-term Care Centers generated USD 4.31 billion in 2025. The U.S. telemedicine market is being operationalized by providers through enterprise platforms, virtual specialty programs, post-discharge monitoring, and staffing models that connect care teams across sites.
Provider demand is shaped by the need to make virtual care clinically useful within existing operations. Adoption is strongest where telemedicine supports access, workforce coverage, readmission management, or continuity of care without creating parallel workflows that clinicians must manage separately.
Payers
Payers accounted for 20% of the market in 2025 and are projected to grow at a 17.2% CAGR (2025–2035). Their role is expanding from reimbursement administration toward active program design, network contracting, and member engagement through virtual-first and hybrid-care offerings.
Payer purchasing power increasingly influences platform requirements. Vendors must demonstrate clinical appropriateness, network quality, utilization-management value, and the ability to integrate virtual services into benefit structures that serve different member populations.
Patients
Patients generated USD 5.39 billion in 2025 and are projected to grow at an 18.5% CAGR (2025–2035). Direct spending, subscription models, and consumer-oriented access channels are broadening the patient-facing revenue base beyond conventional provider- or payer-sponsored encounters.
Consumer demand is likely to remain concentrated in care categories where access friction is high and the clinical interaction can be delivered safely online. However, long-term retention will depend on trust, affordability, care continuity, and credible escalation to in-person services when needed.
GMI Analyst View
We see the most consequential segment opportunity in platforms that unite specialty access with longitudinal data and recurring clinical engagement. Psychiatry, remote monitoring, and consumer-directed channels point to a market in which value is increasingly created through continuity of care and distribution reach, not through isolated virtual encounters.
U.S. Telemedicine Market Regional Analysis
United States Telemedicine Market Analysis
The United States telemedicine market generated USD 21.66 billion in 2022 and USD 25.76 billion in 2023. This progression reflected the continued normalization of virtual care across provider networks, payer programs, and specialty delivery models after the initial pandemic-driven expansion in use.
The U.S. operating environment remains highly consequential because reimbursement, privacy, clinical licensure, and broadband conditions vary across care settings and populations. National platforms must therefore balance the scale benefits of standardized technology with the local realities of provider credentialing, payer contracting, and connectivity.
Rural markets illustrate both the need for and the constraints on telemedicine. Behavioral health, specialty consultation, and chronic-disease management can address persistent access gaps, but adoption depends on infrastructure, local clinical workflows, and reimbursement arrangements that make virtual care practical for providers and patients.
GMI Analyst View
We believe the next phase of U.S. expansion will be determined by execution in underserved and operationally complex settings rather than by broad consumer awareness alone. Vendors that can support audio-capable pathways, safety-net providers, and Medicaid-oriented administrative requirements are likely to gain strategic relevance as the market broadens.
U.S. Telemedicine Market Share & Competitive Landscape
The U.S. telemedicine market share landscape remains fragmented because the market combines clinical service operators, enterprise software providers, remote-monitoring specialists, connected-device manufacturers, and healthcare workflow vendors. Competitive advantage depends on the ability to meet the distinct requirements of provider systems, payers, employers, and consumer channels while sustaining security, interoperability, and clinical quality.
Teladoc Health
Teladoc Health generated USD 2.07 billion in revenue in 2025 and held a 5.8% market share in 2025. Its position reflects a broad footprint spanning virtual consultations, behavioral health, chronic-condition support, and enterprise relationships with health plans and employers.
The company's strategic position is supported by its ability to combine member access, clinical-service delivery, and payer-facing integration. In a fragmented market, that breadth can be valuable where purchasers seek fewer vendor relationships and more coordinated virtual-care capabilities.
American Well (Amwell)
American Well participates primarily as a care-enablement provider, supplying infrastructure that allows health systems, payers, and public-sector organizations to deploy multi-modal virtual-care programs. Its opportunity lies in supporting organizations that want a configurable technology foundation while retaining control over their clinical network and patient experience.
GE Healthcare, Koninklijke Philips N.V., Masimo Corporation, Honeywell International, and AMD Global Telemedicine
These companies contribute through connected monitoring, diagnostic peripherals, virtual-care equipment, clinical command-center capabilities, and supporting infrastructure. Their competitive relevance is linked to the growing importance of device connectivity and actionable patient data in higher-acuity and longitudinal telemedicine models.
Oracle Health, Cisco Systems, Health Catalyst, Veradigm LLC, Updox, Mend, HIPAAVideo.net, and VCDoctor
Enterprise technology and workflow vendors compete through integration, security, communications, data intelligence, and provider usability. Their market role is important because telemedicine programs increasingly depend on compatibility with existing electronic health record, collaboration, and care-coordination environments.
These participants address specialized remote monitoring, acute-care coverage, virtual specialty services, and supply-chain support. Their positioning reflects the continued need for purpose-built clinical models and operational expertise within a market that cannot be served solely through general-purpose video technology.
Recent Industry Developments
Teladoc Health
Teladoc Health announced the availability of virtual-care services through Walmart's Better Care Services platform in May 2026. The arrangement expands consumer access to virtual urgent care, dermatology, and nutrition services through a retail-health distribution channel, reinforcing the importance of consumer-facing partnerships in telemedicine growth. [6]Teladoc Health. "Teladoc Health Expands Access to Care Through Walmart's Better Care Services." ir.teladochealth.com
Amazon Health Services
Amazon announced that Dr. Roy Schoenberg would lead Amazon Health Services effective July 1, 2026. The appointment brings telehealth platform experience into a broader consumer-health portfolio that includes pharmacy, primary care, and health-benefit services, underscoring the strategic value of integrated distribution and technology ecosystems. [5]Amazon. "An Update on Amazon Health Services Leadership." aboutamazon.com
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Authors: Monali Tayade, Sampada Kulkarni
U.S. Telemedicine Market Scope
U.S. Telemedicine Market Size
U.S. Telemedicine Market Trends
U.S. Telemedicine Market Analysis
U.S. Telemedicine Market Share
Report Content
Chapter 1. Research Methodology
1.1 Research approach
1.2 Quality Commitments
1.2.1 GMI AI policy & data integrity commitment
1.2.1.1 Source consistency protocol
1.3 Research Trail & Confidence Scoring
1.3.1 Research Trail Components
1.3.2 Scoring Components
1.4 Data Collection
1.4.1 Partial list of primary sources
1.5 Data mining sources
1.5.1 Paid sources
1.5.1.1 Sources, by region
1.6 Base estimates and calculations
1.6.1 Base year calculation
1.7 Forecast model
1.7.1 Quantified market impact analysis
1.7.1.1 Mathematical impact of growth parameters on forecast
1.8 Research transparency addendum
1.8.1 Source attribution framework
1.8.2 Quality assurance metrics
1.8.3 Our commitment to trust
Chapter 2. Executive Summary
2.1 Industry 360° synopsis
2.2 Key market trends
2.2.1 Component trends
2.2.2 Specialty area trends
2.2.3 End use trends
2.2.4 Regional trends
2.3 TAM analysis, 2027–2035
2.4 CXO perspectives: strategic imperatives
Chapter 3. Industry Insights
3.1 Industry ecosystem analysis
3.1.1 Supplier landscape
3.1.2 Profit margin
3.1.3 Cost structure
3.1.4 Value addition at each stage
3.1.5 Factors affecting the value chain
3.1.6 Disruptions
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic diseases
3.2.1.2 Advances in digital health technologies
3.2.1.3 Favorable regulations and reimbursement policies
3.2.1.4 Increased demand for convenient remote healthcare access
3.2.2 Industry pitfalls and challenges
3.2.2.1 Data privacy and connectivity issues
3.2.2.2 Stringent regulatory policies
3.2.3 Market opportunities
3.3 Growth potential analysis
3.4 Pricing analysis (Driven by Primary Research)
3.4.1 Historical price trend analysis
3.4.2 Pricing strategy by player type (Premium / Value / Cost-plus)
3.5 Regulatory landscape
3.5.1 Federal regulatory framework (FDA, CMS, FCC)
4.6.1 Tier classification criteria & qualifying thresholds
4.6.2 Tier positioning matrix by revenue, geography & innovation
Chapter 5. Market Estimates and Forecast, By Component, 2022–2035 ($ Mn)
5.1 Key trends
5.2 Hardware
5.3 Software
5.3.1 Cloud-based
5.3.2 On-premises
5.4 Services
5.4.1 Tele-consultation
5.4.2 Tele-monitoring
5.4.3 Tele-education/training
5.4.4 Other services
Chapter 6. Market Estimates and Forecast, By Specialty Area, 2022–2035 ($ Mn)
6.1 Key trends
6.2 Pulmonary
6.3 Psychiatry
6.4 Cardiology
6.5 Endocrinology
6.6 Rheumatology
6.7 Gynecology
6.8 Gastroenterology
6.9 Oncology
6.10 Other specialty areas
Chapter 7. Market Estimates and Forecast, By End Use, 2022–2035 ($ Mn)
7.1 Key trends
7.2 Healthcare providers
7.2.1 Hospitals and clinics
7.2.2 Long-term care centers
7.2.3 Other healthcare providers
7.3 Payers
7.4 Patients
7.5 Other end use
Chapter 8. Company Profiles
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at[email protected]
Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below
U.S. Telemedicine Market Size
The U.S. telemedicine market was valued at USD 35.9 billion in 2025, is expected to reach USD 41.64 billion in 2026, and is projected to grow at a 16% CAGR (2025–2035) to reach USD 155.93 billion by 2035. The market covers technology-enabled healthcare delivery across real-time consultations, remote patient monitoring, asynchronous care, and integrated digital platforms serving providers, payers, and patients.
Growth is being shaped by the operational integration of virtual care into clinical workflows rather than by a temporary utilization surge. Provider organizations are using telemedicine to extend specialty capacity, manage chronic conditions between in-person encounters, and support distributed care models, while payers are incorporating virtual access into benefit design, network strategy, and utilization management.
GMI Analyst View
Based on our ongoing engagement with market participants and primary research across the U.S. healthcare ecosystem, U.S. telemedicine market revenue reached USD 30.78 billion in 2024. We view this as evidence that the market had already progressed beyond pandemic-era experimentation before the 2025 base year, shifting competitive emphasis toward measurable clinical performance, payer integration, and durable specialty-care workflows.
U.S. Telemedicine Market Trends, Growth Drivers & GMI Forecast Outlook
The market outlook rests on a widening mismatch between clinical demand and conventional care capacity. Behavioral health access constraints, reimbursement-supported platform adoption, and more efficient digital workflows are expanding demand, while cybersecurity obligations, infrastructure gaps, and reimbursement ambiguity continue to determine where and how quickly deployment can scale.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Behavioral health is a particularly durable demand channel because virtual delivery can address both provider scarcity and the practical barriers that delay treatment, including travel, scheduling, and fragmented local networks. Tele-psychiatry vendors are therefore competing not simply for visit volume, but for placement within payer networks, employer benefits, and provider referral pathways where clinical capacity is a constrained asset.
Medicare participation provides an important commercial floor for health systems and platform vendors making multi-year investments in virtual care infrastructure. Once reimbursement is sufficiently dependable, procurement decisions can shift from isolated video-visit programs toward integrated workflows that connect scheduling, documentation, patient engagement, and monitoring across specialty service lines.
AI integration is also changing the economics of platform deployment. Documentation assistance, triage tools, and asynchronous clinical workflows can reduce administrative friction around each encounter, improving the viability of virtual models in lower-acuity settings where direct clinical time and support costs would otherwise limit adoption.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Cybersecurity has become a commercial qualification issue as much as a technical one. Large providers and health plans increasingly expect vendors to meet demanding security, audit, interoperability, and incident-response requirements before virtual-care programs can move beyond pilots. These obligations favor vendors with established compliance infrastructure and can lengthen sales cycles for smaller specialists.
Broadband limitations create a different constraint: they reduce the practical reach of synchronous care precisely where specialty access needs may be most acute. Audio-first care models can partly mitigate this barrier, but remote monitoring, high-quality video, and data-intensive workflows require connectivity conditions that remain uneven across rural communities.
GMI Analyst View
We expect market development to favor platforms that can combine clinical operations, security controls, analytics, and reimbursement-aware workflows rather than offering video access as a stand-alone service. The principal restraints are likely to shape the timing and channel mix of expansion, not reverse the underlying shift toward digitally coordinated care.
U.S. Telemedicine Market Segment Analysis
By Component
Hardware
The U.S. telemedicine market hardware segment generated USD 7.18 billion in 2025 and is projected to grow at a 14.5% CAGR (2025–2035). Connected diagnostic peripherals, home-monitoring devices, and clinical communication equipment remain essential to care models that require physiological data or specialist oversight beyond a conventional virtual consultation.
Hardware demand is increasingly tied to the design of chronic-care and post-acute programs. Vendors that can connect devices reliably into clinical workflows, rather than merely supply equipment, are better positioned to participate in recurring remote patient management contracts.
Software — Cloud-based
Cloud-based software accounted for 27% of the market in 2025 and is projected to grow at an 18.2% CAGR (2025–2035). Its scale reflects demand for interoperable, multi-site platforms that can support payer programs, provider networks, and distributed clinical teams without the operational burden of locally managed infrastructure.
The segment benefits from the need to coordinate scheduling, documentation, patient communication, and data exchange across care settings. Cloud architectures are particularly relevant where organizations want to standardize virtual-care delivery across multiple specialties and geographies.
Software — On-premises
On-premises software generated USD 2.87 billion in 2025 and is projected to grow at a 9.0% CAGR (2025–2035). The segment remains relevant in organizations with restrictive governance requirements, established clinical technology estates, or deployment preferences that limit migration to externally hosted environments.
Its slower trajectory reflects the trade-off between data-control priorities and the flexibility required for fast feature deployment. Renewal revenue and institutional integration can preserve demand, but the strategic center of gravity is moving toward platforms that can scale across networks more readily.
Services — Tele-consultation
Tele-consultation represented 22% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). It remains the foundational service modality for behavioral health, urgent care, follow-up care, and specialty access, where clinician availability and patient convenience directly influence utilization.
Competitive performance depends on provider-network depth, wait-time management, clinical quality, and reimbursement alignment. As virtual visits become a routine care option, service differentiation is moving from basic access toward specialty appropriateness and continuity with in-person care.
Services — Tele-monitoring
Tele-monitoring generated USD 4.67 billion in 2025 and is projected to grow at an 18.0% CAGR (2025–2035). Demand is being supported by chronic-condition programs that require ongoing visibility into patient status between office visits, particularly where avoidable escalation or hospitalization carries significant clinical and financial consequences.
The segment's appeal lies in its ability to connect device data, clinical review, and patient outreach in a single operating model. Better alert prioritization and workflow integration can make monitoring programs more scalable for providers and more actionable for payers.
Services — Tele-education & Training
Tele-education and training accounted for 5% of the market in 2025 and is projected to grow at a 14.0% CAGR (2025–2035). The segment supports clinical onboarding, workforce development, patient education, and adoption of new digital-care workflows across provider organizations.
Its expansion is linked to implementation intensity. As telemedicine platforms become embedded in more care settings, health systems and specialty practices need repeatable methods to train clinicians, support staff, and patients without disrupting care delivery.
By Specialty Area
Psychiatry
Psychiatry generated USD 7.90 billion in 2025 and is projected to grow at an 18.5% CAGR (2025–2035). The specialty benefits from a structural mismatch between mental health demand and available licensed clinical capacity, making virtual delivery a practical route to expand access across payer, employer, and provider channels.
The segment's commercial strength is reinforced by the suitability of many psychiatric consultations for recurring remote engagement. Sustained growth will depend on provider recruitment, prescribing workflows, clinical governance, and the ability to integrate virtual behavioral health with broader care-management programs.
Cardiology
Cardiology generated USD 6.46 billion in 2025 and is projected to grow at a 16.8% CAGR (2025–2035). Remote oversight is increasingly relevant for patients requiring longitudinal monitoring, follow-up after procedures, and specialist access outside major cardiovascular centers.
The segment benefits from the interaction between specialist consultation and connected data streams. Tele-cardiology models become more valuable when they help clinical teams identify deterioration earlier, coordinate referrals, and manage high-risk patients across hospital and home settings.
Endocrinology
Endocrinology represented 10% of the market in 2025 and is projected to grow at a 17.2% CAGR (2025–2035). Diabetes management, connected monitoring, and preventive coaching make the specialty well suited to longitudinal virtual-care relationships.
The opportunity extends beyond individual consultations. Virtual endocrinology programs can link clinicians, educators, monitoring tools, and payer-sponsored population-health initiatives, giving the segment a role in both specialty access and chronic-disease management.
Oncology
Oncology accounted for 8% of the market in 2025 and is projected to grow at a 16.5% CAGR (2025–2035). Virtual services are increasingly used for navigation, symptom reporting, counseling, and follow-up between in-person treatment events.
Clinical value is strongest where telemedicine complements rather than replaces intensive care delivery. Programs that improve communication between treatment cycles and identify problems early can reduce avoidable patient burden while preserving specialist oversight.
Pulmonology
Pulmonology generated USD 2.87 billion in 2025 and is projected to grow at a 15.0% CAGR (2025–2035). Demand is supported by virtual follow-up and remote monitoring for patients with chronic respiratory conditions who need ongoing assessment but may have limited local access to specialists.
The segment's trajectory depends on reliable patient engagement and usable clinical data. Care models that translate home-based measures into timely clinical action are likely to be more durable than programs centered solely on remote device deployment.
Gastroenterology
Gastroenterology generated USD 2.51 billion in 2025 and is projected to grow at a 15.5% CAGR (2025–2035). Virtual consultations can improve referral triage, chronic-condition follow-up, and preparation for in-person diagnostic or procedural care.
The specialty's telemedicine model is particularly effective when it helps clinicians determine the appropriate next step before patients enter capacity-constrained procedural pathways. This can improve scheduling efficiency while preserving in-person resources for care that requires them.
Gynecology
Gynecology represented 6% of the market in 2025 and is projected to grow at a 14.8% CAGR (2025–2035). Virtual care aligns with patient needs in areas such as counseling, follow-up, reproductive health, and selected prenatal or postpartum interactions.
Privacy, convenience, and continuity make virtual delivery commercially relevant, but sustained adoption depends on how well platforms integrate with established women's-health practices and referral pathways for services requiring in-person examination or intervention.
Rheumatology
Rheumatology accounted for 5% of the market in 2025 and is projected to grow at a 14.2% CAGR (2025–2035). Chronic disease management and the need for periodic specialist follow-up create a practical basis for hybrid care models that combine virtual reviews with targeted in-person assessment.
Tele-rheumatology can be especially meaningful in areas with limited specialist density. Its value proposition centers on maintaining clinical continuity and reducing travel burden without compromising escalation pathways when symptoms require direct examination.
Other Specialties
Other specialties accounted for 16% of the market in 2025 and are projected to grow at a 14.0% CAGR (2025–2035). This grouping includes clinical disciplines where asynchronous review, specialist consultation, and institutional coverage models can extend access beyond traditional appointment-based care.
The diversity of these use cases means adoption will not be uniform. Specialties with clearly defined digital workflows, strong referral economics, or urgent access requirements are more likely to scale than those in which the virtual encounter adds limited clinical value.
By End Use
Healthcare Providers
Healthcare providers generated USD 19.75 billion in 2025 and are projected to grow at a 15.5% CAGR (2025–2035). Within this end-use group, Hospitals & Clinics generated USD 12.57 billion in 2025, while Long-term Care Centers generated USD 4.31 billion in 2025. The U.S. telemedicine market is being operationalized by providers through enterprise platforms, virtual specialty programs, post-discharge monitoring, and staffing models that connect care teams across sites.
Provider demand is shaped by the need to make virtual care clinically useful within existing operations. Adoption is strongest where telemedicine supports access, workforce coverage, readmission management, or continuity of care without creating parallel workflows that clinicians must manage separately.
Payers
Payers accounted for 20% of the market in 2025 and are projected to grow at a 17.2% CAGR (2025–2035). Their role is expanding from reimbursement administration toward active program design, network contracting, and member engagement through virtual-first and hybrid-care offerings.
Payer purchasing power increasingly influences platform requirements. Vendors must demonstrate clinical appropriateness, network quality, utilization-management value, and the ability to integrate virtual services into benefit structures that serve different member populations.
Patients
Patients generated USD 5.39 billion in 2025 and are projected to grow at an 18.5% CAGR (2025–2035). Direct spending, subscription models, and consumer-oriented access channels are broadening the patient-facing revenue base beyond conventional provider- or payer-sponsored encounters.
Consumer demand is likely to remain concentrated in care categories where access friction is high and the clinical interaction can be delivered safely online. However, long-term retention will depend on trust, affordability, care continuity, and credible escalation to in-person services when needed.
GMI Analyst View
We see the most consequential segment opportunity in platforms that unite specialty access with longitudinal data and recurring clinical engagement. Psychiatry, remote monitoring, and consumer-directed channels point to a market in which value is increasingly created through continuity of care and distribution reach, not through isolated virtual encounters.
U.S. Telemedicine Market Regional Analysis
United States Telemedicine Market Analysis
The United States telemedicine market generated USD 21.66 billion in 2022 and USD 25.76 billion in 2023. This progression reflected the continued normalization of virtual care across provider networks, payer programs, and specialty delivery models after the initial pandemic-driven expansion in use.
The U.S. operating environment remains highly consequential because reimbursement, privacy, clinical licensure, and broadband conditions vary across care settings and populations. National platforms must therefore balance the scale benefits of standardized technology with the local realities of provider credentialing, payer contracting, and connectivity.
Rural markets illustrate both the need for and the constraints on telemedicine. Behavioral health, specialty consultation, and chronic-disease management can address persistent access gaps, but adoption depends on infrastructure, local clinical workflows, and reimbursement arrangements that make virtual care practical for providers and patients.
GMI Analyst View
We believe the next phase of U.S. expansion will be determined by execution in underserved and operationally complex settings rather than by broad consumer awareness alone. Vendors that can support audio-capable pathways, safety-net providers, and Medicaid-oriented administrative requirements are likely to gain strategic relevance as the market broadens.
U.S. Telemedicine Market Share & Competitive Landscape
The U.S. telemedicine market share landscape remains fragmented because the market combines clinical service operators, enterprise software providers, remote-monitoring specialists, connected-device manufacturers, and healthcare workflow vendors. Competitive advantage depends on the ability to meet the distinct requirements of provider systems, payers, employers, and consumer channels while sustaining security, interoperability, and clinical quality.
Teladoc Health
Teladoc Health generated USD 2.07 billion in revenue in 2025 and held a 5.8% market share in 2025. Its position reflects a broad footprint spanning virtual consultations, behavioral health, chronic-condition support, and enterprise relationships with health plans and employers.
The company's strategic position is supported by its ability to combine member access, clinical-service delivery, and payer-facing integration. In a fragmented market, that breadth can be valuable where purchasers seek fewer vendor relationships and more coordinated virtual-care capabilities.
American Well (Amwell)
American Well participates primarily as a care-enablement provider, supplying infrastructure that allows health systems, payers, and public-sector organizations to deploy multi-modal virtual-care programs. Its opportunity lies in supporting organizations that want a configurable technology foundation while retaining control over their clinical network and patient experience.
GE Healthcare, Koninklijke Philips N.V., Masimo Corporation, Honeywell International, and AMD Global Telemedicine
These companies contribute through connected monitoring, diagnostic peripherals, virtual-care equipment, clinical command-center capabilities, and supporting infrastructure. Their competitive relevance is linked to the growing importance of device connectivity and actionable patient data in higher-acuity and longitudinal telemedicine models.
Oracle Health, Cisco Systems, Health Catalyst, Veradigm LLC, Updox, Mend, HIPAAVideo.net, and VCDoctor
Enterprise technology and workflow vendors compete through integration, security, communications, data intelligence, and provider usability. Their market role is important because telemedicine programs increasingly depend on compatibility with existing electronic health record, collaboration, and care-coordination environments.
AMC Health, RemetricHealth, SOC Telemed, Eagle Telemedicine, Specialist Telemed, and McKesson Medical-Surgical
These participants address specialized remote monitoring, acute-care coverage, virtual specialty services, and supply-chain support. Their positioning reflects the continued need for purpose-built clinical models and operational expertise within a market that cannot be served solely through general-purpose video technology.
Recent Industry Developments
Teladoc Health
Teladoc Health announced the availability of virtual-care services through Walmart's Better Care Services platform in May 2026. The arrangement expands consumer access to virtual urgent care, dermatology, and nutrition services through a retail-health distribution channel, reinforcing the importance of consumer-facing partnerships in telemedicine growth. [6]Teladoc Health. "Teladoc Health Expands Access to Care Through Walmart's Better Care Services." ir.teladochealth.com
Amazon Health Services
Amazon announced that Dr. Roy Schoenberg would lead Amazon Health Services effective July 1, 2026. The appointment brings telehealth platform experience into a broader consumer-health portfolio that includes pharmacy, primary care, and health-benefit services, underscoring the strategic value of integrated distribution and technology ecosystems. [5]Amazon. "An Update on Amazon Health Services Leadership." aboutamazon.com
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.